A Single and Repeat Dose Trial in Participants With Hepatic Impairment

NCT05009680 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Impairment

Interventions

DRUG: GB1211
DRUG: Placebo

Sponsor

Galecto Biotech AB

Collaborators

[object Object]